Biotech Stocks Icon

Biotech Stocks

Biotech is defined as using technology to change, manipulate, and harness biological processes in order to fulfill a medical need. The applications of biotech are endless and range from genetically modifying foods to creating vaccines. During the height of the coronavirus pandemic, companies like Moderna and BioNTech utilized biotech to create life-saving vaccines that were distributed across the globe.

Recent Biotech Stocks Articles

Why Is Crinetics Pharmaceuticals (CRNX) Stock Up 64% Today?

Crinetics Pharmaceuticals (CRNX) stock is on the rise Monday after the company announced positive clinical trial results.

The 3 Best Pharma Stocks to Buy Now: September 2023

There are pharma stocks to buy for each type of investor. This article explores the best options in the industry.

Why Is Impel Pharmaceuticals (IMPL) Stock Up 32% Today?

Impel Pharmaceuticals (IMPL) stock is on the rise Friday after the company announced an amended agreement with Oaktree Fund Administration.

CRSP Stock Alert: What to Know as CRISPR Therapeutics Co-Founder Steps Down

With CRISPR Therapeutics announcing the departure of its co-founder, investors are also walking for the exits on CRSP stock.

3 Debt-Ridden S&P 500 Stocks to Sell Before It’s Too Late

S&P 500 companies collectively saw second-quarter earnings fall by 4% over last year. A big problem for the index constituents is the higher interest expenses…

Why Is Palisade Bio (PALI) Stock Down 46% Today?

Palisade Bio (PALI) stock is falling on Thursday after the clinical-stage biopharmaceutical company announced a share offering.

Why Is NeuBase Therapeutics (NBSE) Stock Down 27% Today?

NeuBase Therapeutics (NBSE) stock is dropping on Thursday but that's only due to the company coming off a massive rally yesterday.

Why Is China SXT Pharmaceuticals (SXTC) Stock Up 24% Today?

China SXT Pharmaceuticals (SXTC) stock is heading higher on Thursday even without any news from the pharmaceutical company.

7 Pharma Stocks to Buy for Groundbreaking Treatments and Robust Revenue Growth

Pharma stocks can be a great investment, particularly if they have solid performance, revenue growth and a positive outlook.

3 Healthcare Stocks to Sell in September Before They Crash & Burn

The healthcare industry comprises multiple sectors, including biotechnology, pharmaceuticals, and healthcare equipment, each offering a unique and potentially risky opportunity. News regarding FDA approval and…

Why Is NeuBase Therapeutics (NBSE) Stock Up 19% Today?

NeuBase Therapeutics (NBSE) stock is taking off on Wednesday despite a lack of news from the preclinical biopharmaceutical company.

3 Biotech Stocks to Invest In for Big-Time, Long-Term Gains

These biotech stocks to buy and hold offer tremendous upside blending long-term potential with healthcare advances.

The 3 Best Biotech Stocks to Buy Now: September 2023

Biotech stocks have underperformed in the U.S. stock market by a wide margin this year. The sector's most popular index, the iShares Biotechnology ETF (NASDAQ:IBB),…

Robo-Lab Stocks: 3 Robotics Companies Changing the Research Game

Robotics will upend laboratory research just as they upended factories. Bet on the future with these 3 robo-lab company stocks.

7 F-Rated Meme Stocks to Avoid Like the Plague

These popular meme stocks should be avoided at all costs – no matter what you may see on social media.

7 Up-and-Coming Penny Stocks to Put on Your Must-Buy List

So, what are some of the best up-and-coming penny stocks to buy right now? Take a look at these seven. Very attractive in terms of valuation and growth potential, each one is a strong opportunity at today's prices.

3 Beaten-Down Biotech Stocks Bound for a Bounce Back

Biotech stocks are still below their post-pandemic peaks. But these beaten-down biotech stocks could lead the sector to new highs.

7 Undervalued Stocks Due for a Massive Short Squeeze

These are the undervalued short squeeze candidates that are poised for multibagger returns

3 Biotech Stocks Due for a Massive Short Squeeze

These are the biotech short squeeze candidates to buy and hold for a massive rally of up to 100% in the coming quarters.